Cargando…
Anti-inflammatory and antioxidant traditional Chinese Medicine in treatment and prevention of osteoporosis
A metabolic bone disorder called osteoporosis is characterized by decreased bone mass and compromised microarchitecture. This condition can deteriorate bones and raise the risk of fractures. The two main causes of osteoporosis are an increase in osteoclast activity or quantity and a decrease in oste...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10335577/ https://www.ncbi.nlm.nih.gov/pubmed/37441527 http://dx.doi.org/10.3389/fphar.2023.1203767 |
_version_ | 1785071028460847104 |
---|---|
author | Li, Qian Tian, Ciqiu Liu, Xiangjie Li, Dinglin Liu, Hao |
author_facet | Li, Qian Tian, Ciqiu Liu, Xiangjie Li, Dinglin Liu, Hao |
author_sort | Li, Qian |
collection | PubMed |
description | A metabolic bone disorder called osteoporosis is characterized by decreased bone mass and compromised microarchitecture. This condition can deteriorate bones and raise the risk of fractures. The two main causes of osteoporosis are an increase in osteoclast activity or quantity and a decrease in osteoblast viability. Numerous mechanisms, including estrogen shortage, aging, chemical agents, and decreased mechanical loads, have been linked to osteoporosis. Inflammation and oxidative stress have recently been linked to osteoporosis, according to an increasing number of studies. The two primary medications used to treat osteoporosis at the moment are bisphosphonates and selective estrogen receptor modulators (SERMs). These medications work well for osteoporosis brought on by aging and estrogen deprivation, however, they do not target inflammation and oxidative stress-induced osteoporosis. In addition, these drugs have some limitations that are attributed to various side effects that have not been overcome. Traditional Chinese medicine (TCM) has been applied in osteoporosis for many years and has a high safety profile. Therefore, in this review, literature related to botanical drugs that have an effect on inflammation and oxidative stress-induced osteoporosis was searched for. Moreover, the pharmacologically active ingredients of these herbs and the pathways were discussed and may contribute to the discovery of more safe and effective drugs for the treatment of osteoporosis. |
format | Online Article Text |
id | pubmed-10335577 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-103355772023-07-12 Anti-inflammatory and antioxidant traditional Chinese Medicine in treatment and prevention of osteoporosis Li, Qian Tian, Ciqiu Liu, Xiangjie Li, Dinglin Liu, Hao Front Pharmacol Pharmacology A metabolic bone disorder called osteoporosis is characterized by decreased bone mass and compromised microarchitecture. This condition can deteriorate bones and raise the risk of fractures. The two main causes of osteoporosis are an increase in osteoclast activity or quantity and a decrease in osteoblast viability. Numerous mechanisms, including estrogen shortage, aging, chemical agents, and decreased mechanical loads, have been linked to osteoporosis. Inflammation and oxidative stress have recently been linked to osteoporosis, according to an increasing number of studies. The two primary medications used to treat osteoporosis at the moment are bisphosphonates and selective estrogen receptor modulators (SERMs). These medications work well for osteoporosis brought on by aging and estrogen deprivation, however, they do not target inflammation and oxidative stress-induced osteoporosis. In addition, these drugs have some limitations that are attributed to various side effects that have not been overcome. Traditional Chinese medicine (TCM) has been applied in osteoporosis for many years and has a high safety profile. Therefore, in this review, literature related to botanical drugs that have an effect on inflammation and oxidative stress-induced osteoporosis was searched for. Moreover, the pharmacologically active ingredients of these herbs and the pathways were discussed and may contribute to the discovery of more safe and effective drugs for the treatment of osteoporosis. Frontiers Media S.A. 2023-06-27 /pmc/articles/PMC10335577/ /pubmed/37441527 http://dx.doi.org/10.3389/fphar.2023.1203767 Text en Copyright © 2023 Li, Tian, Liu, Li and Liu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Li, Qian Tian, Ciqiu Liu, Xiangjie Li, Dinglin Liu, Hao Anti-inflammatory and antioxidant traditional Chinese Medicine in treatment and prevention of osteoporosis |
title | Anti-inflammatory and antioxidant traditional Chinese Medicine in treatment and prevention of osteoporosis |
title_full | Anti-inflammatory and antioxidant traditional Chinese Medicine in treatment and prevention of osteoporosis |
title_fullStr | Anti-inflammatory and antioxidant traditional Chinese Medicine in treatment and prevention of osteoporosis |
title_full_unstemmed | Anti-inflammatory and antioxidant traditional Chinese Medicine in treatment and prevention of osteoporosis |
title_short | Anti-inflammatory and antioxidant traditional Chinese Medicine in treatment and prevention of osteoporosis |
title_sort | anti-inflammatory and antioxidant traditional chinese medicine in treatment and prevention of osteoporosis |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10335577/ https://www.ncbi.nlm.nih.gov/pubmed/37441527 http://dx.doi.org/10.3389/fphar.2023.1203767 |
work_keys_str_mv | AT liqian antiinflammatoryandantioxidanttraditionalchinesemedicineintreatmentandpreventionofosteoporosis AT tianciqiu antiinflammatoryandantioxidanttraditionalchinesemedicineintreatmentandpreventionofosteoporosis AT liuxiangjie antiinflammatoryandantioxidanttraditionalchinesemedicineintreatmentandpreventionofosteoporosis AT lidinglin antiinflammatoryandantioxidanttraditionalchinesemedicineintreatmentandpreventionofosteoporosis AT liuhao antiinflammatoryandantioxidanttraditionalchinesemedicineintreatmentandpreventionofosteoporosis |